Prevalence of incompletely penetrant Huntington's disease alleles among individuals with major depressive disorder
- PMID: 20360314
- PMCID: PMC3114558
- DOI: 10.1176/appi.ajp.2009.09070973
Prevalence of incompletely penetrant Huntington's disease alleles among individuals with major depressive disorder
Abstract
Objective: Presymptomatic individuals with the Huntingtin (HTT) CAG expansion mutation that causes Huntington's disease may have higher levels of depressive symptoms than healthy comparison populations. However, the prevalence of HTT CAG repeat expansions among individuals diagnosed with major depressive disorder has not been established.
Method: This was a case-control genetic association study of HTT CAG allele size in two discovery cohorts of individuals with major depressive disorder and comparison subjects without major depression as well as a replication cohort of individuals with major depression and comparison subjects without major depression.
Results: CAG repeat lengths of 36 or greater were observed in six of 3,054 chromosomes from individuals with major depression, compared with none of 4,155 chromosomes from comparison subjects. In a third cohort, one expanded allele was observed among 1,202 chromosomes in the major depression group, compared with none of 2,678 chromosomes in comparison subjects. No clear pattern of clinical features was shared among individuals with the expanded repeats.
Conclusions: In clinical populations of individuals diagnosed with major depression, approximately 3 in 1,000 carried expanded HTT CAG alleles.
Figures
Similar articles
-
Prevalence of Huntington's disease gene CAG trinucleotide repeat alleles in patients with bipolar disorder.Bipolar Disord. 2015 Jun;17(4):403-8. doi: 10.1111/bdi.12289. Epub 2015 Feb 26. Bipolar Disord. 2015. PMID: 25726852 Free PMC article.
-
Huntingtin CAG repeat size variations below the Huntington's disease threshold: associations with depression, anxiety and basal ganglia structure.Eur J Hum Genet. 2025 May;33(5):624-632. doi: 10.1038/s41431-024-01737-1. Epub 2024 Nov 21. Eur J Hum Genet. 2025. PMID: 39572770 Free PMC article.
-
A worldwide study of the Huntington's disease mutation. The sensitivity and specificity of measuring CAG repeats.N Engl J Med. 1994 May 19;330(20):1401-6. doi: 10.1056/NEJM199405193302001. N Engl J Med. 1994. PMID: 8159192
-
Interrupting sequence variants and age of onset in Huntington's disease: clinical implications and emerging therapies.Lancet Neurol. 2020 Nov;19(11):930-939. doi: 10.1016/S1474-4422(20)30343-4. Lancet Neurol. 2020. PMID: 33098802 Review.
-
Huntington's disease.Semin Cell Biol. 1995 Feb;6(1):21-8. doi: 10.1016/1043-4682(95)90011-x. Semin Cell Biol. 1995. PMID: 7620118 Review.
Cited by
-
Retinal Nerve Fiber Layer Thickness Measurement by Spectral-Domain Optical Coherence Tomography in Patients with Major Depressive Disorder.Noro Psikiyatr Ars. 2017 Mar;54(1):62-66. doi: 10.5152/npa.2015.10115. Noro Psikiyatr Ars. 2017. PMID: 28566961 Free PMC article.
-
The HTT CAG-Expansion Mutation Determines Age at Death but Not Disease Duration in Huntington Disease.Am J Hum Genet. 2016 Feb 4;98(2):287-98. doi: 10.1016/j.ajhg.2015.12.018. Am J Hum Genet. 2016. PMID: 26849111 Free PMC article.
-
[Huntington's chorea mimicking adult attention deficit hyperactivity disorder].Nervenarzt. 2011 Mar;82(3):360-2. doi: 10.1007/s00115-011-3251-5. Nervenarzt. 2011. PMID: 21308357 German. No abstract available.
-
Depressive symptoms in prodromal Huntington's Disease correlate with Stroop-interference related functional connectivity in the ventromedial prefrontal cortex.Psychiatry Res. 2012 Aug-Sep;203(2-3):166-74. doi: 10.1016/j.pscychresns.2012.01.002. Epub 2012 Sep 11. Psychiatry Res. 2012. PMID: 22974690 Free PMC article.
-
Tandem Repeats and Repeatomes: Delving Deeper into the 'Dark Matter' of Genomes.EBioMedicine. 2018 May;31:3-4. doi: 10.1016/j.ebiom.2018.04.004. Epub 2018 Apr 14. EBioMedicine. 2018. PMID: 29665999 Free PMC article. No abstract available.
References
-
- A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes (the Huntington’s Disease Collaborative Research Group) Cell. 1993;72:971–983. - PubMed
-
- MacDonald ME, Gines S, Gusella JF, Wheeler VC. Huntington’s disease. Neuromolecular Med. 2003;4:7–20. - PubMed
-
- Semaka A, Creighton S, Warby S, Hayden MR. Predictive testing for Huntington disease: interpretation and significance of intermediate alleles. Clin Genet. 2006;70:283–294. - PubMed
-
- Kirkwood SC, Su JL, Conneally P, Foroud T. Progression of symptoms in the early and middle stages of Huntington disease. Arch Neurol. 2001;58:273–278. - PubMed
-
- Duff K, Paulsen JS, Beglinger LJ, Langbehn DR, Stout JC Predict-HD Investigators of the Huntington Study Group. Psychiatric symptoms in Huntington’s disease before diagnosis: the Predict-HD study. Biol Psychiatry. 2007;62:1341–1346. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical